Reduced hnRNPA3 increases C9orf72 repeat RNA levels and dipeptide‐repeat protein deposition
Authors:
- Kohji MoriKMKohji Mori
- Bavarian Brain Banking AllianceBABavarian Brain Banking Alliance
- Dieter EdbauerDEDieter Edbauer
- 26 July 2016
- journal article
- Published by Springer Nature in EMBO Reports
- Vol. 17 (9) , 1314-1325
Abstract
Intronic hexanucleotide (G4C2) repeat expansions in C9orf72 are genetically associated with frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). The repeat RNA accumulates within RNA foci but is also translated into disease characterizing dipeptide repeat proteins (DPR). Repeat‐dependent toxicity may affect nuclear import. hnRNPA3 is a heterogeneous nuclear ribonucleoprotein, which specifically binds to the G4C2 repeat RNA. We now report that a reduction of nuclear hnRNPA3 leads to an increase of the repeat RNA as well as DPR production and deposition in primary neurons and a novel tissue culture model that reproduces features of the C9orf72 pathology. In fibroblasts derived from patients carrying extended C9orf72 repeats, nuclear RNA foci accumulated upon reduction of hnRNPA3. Neurons in the hippocampus of C9orf72 patients are frequently devoid of hnRNPA3. Reduced nuclear hnRNPA3 in the hippocampus of patients with extended C9orf72 repeats correlates with increased DPR deposition. Thus, reduced hnRNPA3 expression in C9orf72 cases leads to increased levels of the repeat RNA as well as enhanced production and deposition of DPR proteins and RNA foci. Synopsis FTLD/ALS‐associated repeat expansions in C9orf72 are translated into dipeptide repeat proteins. Reduction of repeat‐binding hnRNPA3 increases levels of the repeat RNA and enhances production of dipeptide repeat proteins and RNA foci. Reduction of nuclear hnRNPA3 increases levels of the C9orf72 repeat RNA. Reduction of nuclear hnRNPA3 increases RNA foci formation and enhances generation and deposition of dipeptide repeat proteins. Reduced nuclear hnRNPA3 in the hippocampus of patients with extended C9orf72 repeats correlates with increased dipeptide repeat protein deposition.Keywords
Funding Information
- European Research Council (617198)
- Seventh Framework Programme (FP7/2007‐2013)
- Deutsche Forschungsgemeinschaft (EXC1010)
- MetLife Foundation
- Helmholtz-Gemeinschaft (VI‐510)
- NOMIS Stiftung
This publication has 27 references indexed in Scilit:
- Hexanucleotide Repeats in ALS/FTD Form Length-Dependent RNA Foci, Sequester RNA Binding Proteins, and Are NeurotoxicCell Reports, 2013
- C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA fociActa Neuropathologica, 2013
- Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteinsActa Neuropathologica, 2013
- Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALSActa Neuropathologica, 2013
- RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense InterventionNeuron, 2013
- The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALSScience, 2013
- Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALSNature, 2013
- Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALSNeuron, 2013
- Loss of fused in sarcoma (FUS) promotes pathological Tau splicingEMBO Reports, 2012
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALSNeuron, 2011